1. Ablashi DV, Chatlynne LG, Whitman Jr JE, Cesarman E (2002) Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15: 439–464
2. Antman K, Chang Y (2000) Kaposi's sarcoma. N Engl J Med 342: 1027–1038
3. Ariyoshi K, Schim vdL, Cook P, Whitby D, Corrah T, Jaffar S, Cham F, Sabally S, O'Donovan D, Weiss RA, Schulz TF, Whittle H (1998) Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1: 193–199
4. Biggar RJ, Horm J, Fraumeni Jr JF, Greene MH, Goedert JJ (1984) Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973–81. J Natl Cancer Inst 73: 89–94
5. Brenner B, Weissmann-Brenner A, Rakowsky E, Weltfriend S, Fenig E, Friedman-Birnbaum R, Sulkes A, Linn S (2002) Classical Kaposi sarcoma: prognostic factor analysis of 248 patients. Cancer 95: 1982–1987